Reduced maternal corticosteroid‐binding globulin and cortisol levels in pre‐eclampsia and gamete recipient pregnancies
- 15 April 2007
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 66 (6), 869-877
- https://doi.org/10.1111/j.1365-2265.2007.02826.x
Abstract
Objective To measure and contrast maternal cortisol and corticosteroid‐binding globulin (CBG) levels in pregnancies with normal outcomes, pre‐eclampsia, intrauterine growth restriction (IUGR) and in gamete recipients. Study design Prospective study of 93 women at high risk of pre‐eclampsia, including gamete recipients (n = 22) and 33 controls. Plasma total and free cortisol and CBG were measured every 2 weeks from 16 weeks’ gestation until delivery. Results Forty‐two per cent of the high‐risk group had complications, including pre‐eclampsia (n = 11), gestational hypertension (n = 16) and small‐for‐gestational‐age (SGA) neonates (n = 12). There were no complications in the controls. In all groups, plasma CBG concentrations increased progressively across gestation (P < 0·05), in parallel to total cortisol, but fell significantly from 36 weeks’ gestation onwards, with a corresponding rise in free cortisol concentrations. In pre‐eclampsia and gestational hypertension, plasma CBG, and total and free cortisol concentrations were lower from 36 weeks onwards (P < 0·05). In IUGR, plasma CBG concentrations were suppressed from 28 weeks’ gestation until delivery (P < 0·05), but with no significant difference in plasma total and free cortisol. Gamete recipients had significantly lower plasma CBG from 20 weeks’ gestation onwards, and plasma total and free cortisol were reduced at 24 and 32 weeks onwards, respectively. Conclusions Maternal plasma CBG, total and free cortisol concentrations are reduced in pre‐eclampsia/gestational hypertension, and markedly reduced in gamete recipients. Low CBG may be due to reduced synthesis or enhanced inflammation‐driven degradation. Low maternal cortisol may be due to a lack of placental corticotropin‐releasing hormone or reduced maternal ACTH, driving cortisol production. Low maternal cortisol may influence the foetal hypothalamic–pituitary–adrenal axis and disease patterns later in life following complicated pregnancy.Keywords
This publication has 55 references indexed in Scilit:
- Outcomes From Assisted Reproductive TechnologyObstetrics & Gynecology, 2006
- Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsiaThe Lancet, 2002
- Corticosteroid-Binding Globulin Status at the Fetomaternal Interface During Human Term Pregnancy1Biology of Reproduction, 2001
- 11β-Hydroxysteroid Dehydrogenase and Its Inhibitors in Hypertensive PregnancyHypertension, 1995
- Corticotropin-releasing hormone and pituitary-adrenal hormones in pregnancies complicated by chronic hypertensionAmerican Journal of Obstetrics and Gynecology, 1995
- Involvement of Placental Neurohormones in Human ParturitionaAnnals of the New York Academy of Sciences, 1991
- Specific steroid-binding glycoproteins of human blood plasma: Novel data on their structure and functionJournal of Steroid Biochemistry, 1990
- Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulinJournal of Steroid Biochemistry, 1987
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancyJournal of Steroid Biochemistry, 1982